Canaccord Genuity Group reaffirmed their speculative buy rating on shares of MYCELX Technologies (LON:MYX – Free Report) in a research note released on Tuesday morning, Marketbeat.com reports. Canaccord Genuity Group currently has a GBX 95 ($1.27) target price on the stock.
MYCELX Technologies Stock Performance
LON:MYX opened at GBX 38.50 ($0.52) on Tuesday. The company has a current ratio of 2.36, a quick ratio of 2.97 and a debt-to-equity ratio of 12.42. The company’s 50-day moving average price is GBX 51.86 and its 200-day moving average price is GBX 54.45. MYCELX Technologies has a twelve month low of GBX 36.25 ($0.49) and a twelve month high of GBX 71.64 ($0.96). The company has a market cap of £9.38 million, a P/E ratio of -320.83 and a beta of 1.00.
Insiders Place Their Bets
In other news, insider André Schnabl bought 48,836 shares of MYCELX Technologies stock in a transaction on Friday, August 23rd. The shares were bought at an average cost of GBX 51 ($0.68) per share, with a total value of £24,906.36 ($33,350.78). 19.26% of the stock is owned by insiders.
MYCELX Technologies Company Profile
MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the oil and gas, power, marine, and heavy manufacturing sectors in the Middle East, the United States, Nigeria, Australia and internationally. The company offers oil removal solutions for upstream produced water to oil companies; and hydrocarbons removal services from downstream process wastewater that are used in petrochemical facilities and refineries.
See Also
- Five stocks we like better than MYCELX Technologies
- How to Invest in the Best Canadian Stocks
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- How to Calculate Stock Profit
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for MYCELX Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYCELX Technologies and related companies with MarketBeat.com's FREE daily email newsletter.